# Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

> **NCT02503644** · PHASE2 · COMPLETED · sponsor: **Inventiva Pharma** · enrollment: 145 (actual)

## Conditions studied

- Scleroderma, Diffuse
- Diffuse Cutaneous Systemic Sclerosis

## Interventions

- **DRUG:** IVA337
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02503644
- **Lead sponsor:** Inventiva Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-29
- **Primary completion:** 2018-10
- **Final completion:** 2018-10-12
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2019-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02503644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02503644, "Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02503644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*